Drugs / ASN-1324
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04601766 | Oct → Dec 2020 | urinary bladder cancer | Asieris Pharmaceuticals (AUS) Pty Ltd. | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ASN-1324 | “1501 ER Tablets 3 382 mg ASN-1324, 1 tablet” NCT04601766 ↗ |